approval · primary record
EPINEPHRINE
FDA · NDA · 2025-04-30
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-04-30 |
| Brand | AUVI-Q |
| Sponsor | KALEO INC |
| Route | INTRAMUSCULAR, SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:21.154Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:EPINEPHRINE:2025-04-30
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.